JULIA
ORIGÜEN SABATER
Profesora asociada de Ciencias de la Salud
![Foto de JULIA](/img/nophoto.png)
![Foto de Hospital Universitario Marqués de Valdecilla](/img/noimage_org.png)
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (12)
2021
-
Efficacy and safety of oral fosfomycin for asymptomatic bacteriuria in kidney transplant recipients: Results from a spanish multicenter cohort
Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 5
2020
-
Oral fosfomycin for the treatment of lower urinary tract infections among kidney transplant recipients—Results of a Spanish multicenter cohort
American Journal of Transplantation, Vol. 20, Núm. 2, pp. 451-462
2018
-
Comparison of Predictors and Mortality between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae
Infection Control and Hospital Epidemiology, Vol. 39, Núm. 6, pp. 660-667
-
Impact of Staphylococcus aureus phenotype and genotype on the clinical characteristics and outcome of infective endocarditis. A multicentre, longitudinal, prospective, observational study
Clinical Microbiology and Infection, Vol. 24, Núm. 9, pp. 985-991
-
Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae
International Journal of Antimicrobial Agents, Vol. 52, Núm. 5, pp. 577-585
2017
-
Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae
The Journal of antimicrobial chemotherapy, Vol. 72, Núm. 3, pp. 906-913
-
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study
International Journal of Antimicrobial Agents, Vol. 50, Núm. 5, pp. 664-672
2016
-
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae
Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 7, pp. 4159-4169
-
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 6, pp. 1672-1680
2015
-
Executive summary. Management of urinary tract infection in solid organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 33, Núm. 10, pp. 680-687
-
Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe
Clinical Microbiology and Infection, Vol. 21, Núm. 11, pp. 1040.e11-1040.e18
-
Management of urinary tract infection in solid organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 33, Núm. 10, pp. 679.e1-679.e21